Brain metastases in patients with germ cell tumors: Prognostic factors and treatment options - An analysis from the Global Germ Cell Cancer Group.
Journal of Clinical Oncology.
Times cited: 30
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial.
The Lancet Oncology.
Times cited: 176
Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
New England Journal of Medicine.
Times cited: 998